Lv3
366 积分 2023-09-08 加入
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trial
3天前
已完结
CLO26-112: Durvalumab Versus Pembrolizumab With Gemcitabine and Cisplatin in First-Line Treatment of Advanced Biliary Tract Cancer: A Real-World Comparative Effectiveness Analysis
3天前
求助中
Efficacy and safety of immune checkpoint inhibitors in hepatocellular carcinoma: a comprehensive umbrella review of meta-analyses
5个月前
已完结
Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma
5个月前
已完结
Hyperprogression in hepatocellular carcinoma: Illusion or reality?
9个月前
已关闭
Details of human epidermal growth factor receptor 2 status in 454 cases of biliary tract cancer
9个月前
已完结
Details of human epidermal growth factor receptor 2 status in 454 cases of biliary tract cancer
9个月前
已完结
皖公网安备34019202002308
